DrugDashboards

Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release

Hydrocodone Polistirex and Chlorpheniramine Polistirex · HYDROCODONE BITARTRATE 10 mg/5mL; CHLORPHENIRAMINE MALEATE 8 mg/5mL · Suspension, Extended Release · Oral · Bryant Ranch Prepack

NDC 63629-2303-01 · 1 BOTTLE, UNIT-DOSE in 1 CARTON / 115 mL in 1 BOTTLE, UNIT-DOSE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for hydrocodone polistirex and chlorpheniramine polistirex (other) in the next 90 days

price up 30% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA091632
TE code
Approval date
Oct 1, 2010
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Hydrocodone Polistirex and Chlorpheniramine Polistirex (Suspension, Extended Release)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackHYDROCODONE BITARTRATE 10 mg/5mL; CHLORPHENIRAMINE MALEATE 8 mg/5mLAug 26, 2026Sep 3, 2026
Cranbury Pharmaceuticals, LLCHYDROCODONE BITARTRATE 10 mg/5mL; CHLORPHENIRAMINE MALEATE 8 mg/5mLAug 26, 2026Sep 2, 2026
Bryant Ranch PrepackHYDROCODONE BITARTRATE 8 mg/5mL; CHLORPHENIRAMINE MALEATE 10 mg/5mLJul 22, 2026Aug 22, 2026
Cranbury Pharmaceuticals, LLCHYDROCODONE BITARTRATE 8 mg/5mL; CHLORPHENIRAMINE MALEATE 10 mg/5mLJul 22, 2026Aug 19, 2026
Bryant Ranch PrepackCHLORPHENIRAMINE MALEATE 8 mg/5mL; HYDROCODONE BITARTRATE 10 mg/5mLJul 15, 2026Jul 18, 2026
Cranbury Pharmaceuticals, LLCCHLORPHENIRAMINE MALEATE 8 mg/5mL; HYDROCODONE BITARTRATE 10 mg/5mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release — NDC 63629-2303-01," retrieved September 3, 2026, https://drugdashboards.com/drug/63629230301.

Free to cite with attribution — see how the data is put together.